Quo-Test A1c System

Assay, Glycosylated Hemoglobin

EKF-diagnostic GmbH

The following data is part of a premarket notification filed by Ekf-diagnostic Gmbh with the FDA for Quo-test A1c System.

Pre-market Notification Details

Device IDK180509
510k NumberK180509
Device Name:Quo-Test A1c System
ClassificationAssay, Glycosylated Hemoglobin
Applicant EKF-diagnostic GmbH Ebendorfer Chaussee 3 Barleben,  DE 30179
ContactMick Fenton
CorrespondentKaren Golomb
EKF-diagnostic GmbH Ebendorfer Chaussee 3 39179 Barleben,  DE
Product CodeLCP  
CFR Regulation Number864.7470 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeDual Track
3rd Party ReviewedNo
Combination ProductNo
Date Received2018-02-27
Decision Date2019-02-16
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.